Article Details

Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous ...

Retrieved on: 2022-09-13 07:55:05

Tags for this article:

Click the tags to see associated articles and topics

Positive Neoadjuvant Libtayo® (cemiplimab) Monotherapy Data in Resectable Cutaneous .... View article details on hiswai:

Excerpt

Details: Category: Antibodies: Published on Tuesday, 13 September 2022 09:52 ... Libtayo is a fully human monoclonal antibody targeting the immune ...

Article found on: pipelinereview.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up